Dr Trieu is a leading expert in global food policy and sodium reduction, currently serving as the Co-Director of the World Health Organization Collaborating Centre on Population Salt Reduction at The George Institute for Global Health. With a distinguished career in public health, Dr Trieu has advanced nutrition policies and programs aimed at reducing diet-related diseases worldwide, particularly among disadvantaged populations.

Dr Trieu holds a PhD in Medicine from The University of Sydney, Australia and has received several prestigious fellowships, including the NHMRC Early Career Fellowship and the National Heart Foundation of Australia Postdoctoral Fellowship.

As Program Lead - Nutrition Implementation Research at The George Institute, Dr Trieu plays a pivotal role in shaping effective food policies and innovative nutrition programs. Her work focuses on the practical application and implementation of evidence-based nutrition approaches. This includes leading a program of work to change the world’s salt supply from regular to potassium-enriched salt as a strategy to reduce cardiovascular diseases.  As well as developing and adapting Food is Medicine programs for disadvantaged communities in Australia. Her expertise extends internationally, providing guidance and support to many low- and middle-income countries in implementing evidence-based strategies for better health outcomes.

In addition to her research, Dr Trieu serves as a Conjoint Senior Lecturer at the Faculty of Medicine, The University of New South Wales, where she contributes to the academic development of future public health leaders.

Dr Trieu continues to make significant impact on improving global nutrition and reducing the burden of diet-related diseases through strategic policy and research.

Professor Rodgers has a track record in cardiovascular disease prevention, innovation and public-private partnerships, with an interest in scale-able interventions to address major risks to health. He is currently Acting Director of the Cardiovascular Division at The George Institute, Australia and Chair of Clinical Epidemiology, Faculty of Medicine, Imperial College of London.

After graduating in medicine in the United Kingdom he trained in epidemiology and public health in New Zealand. He was the Principal Author of the 2002 World Health Report, the main annual publication for WHO. Professor Rodgers has led developments of an affordable four-in-one cardiovascular combination pill ('polypill'). He led a clinical trial program in economically developed and developing countries, funded by the Wellcome Trust, European Union and others.  

Professor Rodgers also developed a world first cell phone based smoking cessation programme for youth, which disseminated proven health support messages in an age-appropriate, affordable medium.  Over 6,000 patients were involved in clinical trials that demonstrated a 50% increase in quit rates. The service has been rolled out by Departments of Health in NZ, UK and India, with over 2 million users to date. A follow-on program delivering cognitive behavioural therapy for depression prevention was successfully trialled among 1,200 at-risk teenagers.